- $2.13m
- $49.13m
- $192.35m
Brief: Zynex Inc Says SEC Concluded Investigation Into Zynex, No Enforcement Action Planned
Brief: Zynex Inc Resolves Federal Investigation Into Business Practices
Brief: Zynex Secures $22.3 Million Dip Facility From Lenders And CEO
Brief: Zynex Financial Restructuring Puts Company On Path To Long-Term Success
NASDAQ RESUMED AT 03:38 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:49 PM
Medical device firm Zynex's Q3 revenue misses expectations
Brief: Zynex Q3 Revenue USD 13.4 Million
Brief: Zynex Terminated Positions Of A Majority Of Zms Employees
Brief: Zynex Announces Arrival Of Steven Dyson As CEO
Zynex Inc reports results for the quarter ended June 30 - Earnings Summary
Medtech Zynex's Q2 revenue falls more than expected, names new CEO, suspends forecast
Zynex Inc expected to post a loss of 20 cents a share - Earnings Preview
Zynex Inc expected to post a loss of 20 cents a share - Earnings Preview
Newscasts - Dalai Lama turns 90, gets global support in challenge for China
Brief: Tricare Temporary Payment Suspension Update
Brief: Zynex Announces Steven Dyson As New CEO
Brief: Zynex Expects $5 Million In Annualized Cost Savings From Workforce Reduction - SEC Filing
Zynex Inc reports results for the quarter ended March 31 - Earnings Summary